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The sulfur-containing antibiotic thiolutin has been shown to be a potent,
reversible inhibitor of the growth of Saccharomyces cerevisiae. Viability was
unaffected over the concentration range of 4 to 100 ug/ml. At concentrations as
low as 2 sg/ml, the drug inhibited ribonucleic acid (RNA) and protein synthesis
in whole cells and spheroplasts. At these low concentrations, protein synthesis
continued for a short period of time after RNA synthesis was completely stopped.
With higher drug concentrations (greater than 20 ;g/ml) protein synthesis was
inhibited; concentrations of thiolutin up to 100 ,ug/ml did not affect translocation
or peptide bond formation in cell-free protein-synthesizing systems from yeast.
The effect of thiolutin on the activity of partially purified deoxyribonucleic
acid-dependent RNA polymerases was examined, and the drug was found to be a
potent inhibitor of RNA synthesis in vitro. Inhibition was greatest when the
polymerase was preincubated with thiolutin. Several mechanisms are discussed
to explain the multiple effects of thiolutin on S. cerevisiae. Since the action of the
drug is easily reversed, thiolutin may prove to be of use in studies of various
stages of yeast growth.
In bacteria, antibiotics have played useful
roles in providing genetic markers for a number
of macromolecules and have also been used in
dissecting the roles of macromolecules in con-
certed reactions. The use of antibiotics in yeast
has not been exploited to the same extent. This
is due, in part, to the fact that many of the
better-characterized antibiotics do not affect
Saccharomyces cerevisiae, presumably because
the yeast cell is impermeable to these com-
pounds. Many antifungal compounds have been
isolated during the process of screening for
antimicrobial agents, and, although they may
not be medically useful because of their toxicity
properties, it is quite possible that some of these
compounds may have biochemical applications.
This report describes our initial studies on the
mode of action of one such antifungal agent,
thiolutin.
MATERIALS AND METHODS
Yeast strains, growth media, and preparation of
Spheroplasts. The yeast strain used during the
729
course of this work was S. cerevisiae Y166 (atrp5 his4
MA1). Experiments with whole cells were carried out
in YM-5 medium and those with spheroplasts were
carried out in YM-5 medium containing 0.4 M mag-
nesium sulfate (12). Solid media for strains was
YEPD (1% yeast extract, 2% peptone, 2% glucose,
and 2% agar).
Cell growth was followed by measurements of the
optical density at 550 nm (OD5,0) in a Bausch &
Lomb Spectronic 20 colorimeter. An optical density of
0.32 corresponded to 107 cells/ml. Viability of cell
cultures was determined by serial dilution and plating
on YEPD mediuxm; plates were scored after 48 h of
incubation at 30 C.
The procedure of Hutchison and Hartwell (12) was
used for the preparation of spheroplasts. Treatment
with 1% glusulase in 1 M sorbitol for 1 to 2 h at 27 C
was adequate to convert cells to spheroplasts, Meta-
bolically active spheroplasts were obtained by har-
vesting spheroplasts after glusulase treatment and in-
cubating them for 2 to 3 h at 27 C in YM-5 medium
containing 0.4 M MgSO4.
Incorporation of labeled precursors. The proce-
dure described by Hartwell (9) was followed. Ribonu-
cleic acid (RNA) and protein synthesis were moni-
tored simultaneously by use of a mixture of 'H-
labeled uridine and "4C-labeled leucine or recon-
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730 JIMENEZ, TIPPER, AND DAVIES
stituted protein hydrolysate (Amersham-Searle). At
various times, 1-ml samples were removed and added
to 1 ml of ice-cold 10% trichloroacetic acid; the
resulting precipitates were collected on glass-fiber
circles (Whatman GF/C), washed several times with
cold trichloroacetic acid, dried, and counted in a
toluene-based scintillation fluid.
PreparAtion and analysis of polyribosomes. Me-
tabolism in spheroplasts was stopped by the addition
of cycloheximide (200 Mg/ml) to a 5-ml culture. The
culture was immediately cooled in ice, and sphero-
plasts were collected by centrifugation at 8,000 x g for
5 min in a Sorvall SS-34 rotor. The pellets were
resuspended in 0.25 ml of ice-cold Tris-hydrochloride
lysis buffer (10 mM tris[hydroxymethyl]-aminometh-
ane, pH 7.4, 100 mM NaCl, and 30 mM MgCl2),
0.5% sodium deoxycholate (DOC), and 0.75% Brij 58;
they were immediately layered on top of a 5-ml 10 to
30% sucrose gradient in lysis buffer and centrifuged
for 35 min at 35,000 rpm in a Spinco SW50.1 rotor.
The gradients were analyzed at 254 nm in an Isco
model D/UA-2 gradient analyzer. If the incorporation
of labeled precursors into polyribosomes was to be
measured, 33 fractions were collected and precipi-
tated with ice-cold 15% trichloroacetic acid. The
percentage of ribosomes present as polyribosomes was
determined by planimetric tracing, or by weighing the
areas under the peaks.
Analysis of radioactively labeled RNA. Sphero-
plast cultures (5 ml) were centrifuged for 2 min at
10,000 x g, and the pellets were lysed with 0.25 ml of a
solution containing 100 mM NaCl, 50 mM sodium
acetate, pH 5.4, 10 mM ethylenediaminetetraacetic
acid (EDTA), and 0.5% sodium dodecyl sulfate
(SDS). The lysates were layered on a 5-ml 5 to 20%
sucrose gradient made in the same buffer and were
centrifuged for 2.5 h at 40,000 rpm in a Spinco SW50.1
rotor. The gradients were analyzed in an Isco gradient
analyzer and 6-drop fractions were collected on
2.4-cm disks of filter paper (Whatman 3 MM). Fifty-
eight fractions were collected from each 5-ml gradi-
ent. The disks were washed three times with ice-cold
10% trichloroacetic acid, once with alcohol-ether
(1: 1), and once with ether. The filters were air-dried
and counted in a toluene-based scintillation fluid.
Polypeptide synthesis in vitro. A method de-
scribed elsewhere (A. Jimenez, B. Littlewood, and J.
Davies, in D. Vazquez [ed.], Molecular mechanisms
in antibiotic action on protein biosynthesis and mem-
branes, Elsevier, in press) was modified as follows.
The source of supematant enzymes was the S-150
fraction precipitated with ammonium sulfate. The 40
to 70% precipitate was resuspended in a small volume
of 20 mM Tris-hydrochloride (pH 7.4)-l mM dithio-
threitol (DTT) and dialyzed against the same buffer;
small samples were stored at -30 C. Incubation
mixtures (0.1 ml) for polyuridylic acid (poly U)-
directed polyphenylalanine synthesis contained 50
mM Tris-hydrochloride, pH 7.7, 12.5 mM magnesium
acetate, 80 mM KCl, 4 mM creatine phosphate, 40 Mg
of creatine phosphokinase/ml, 500 Mg of yeast transfer
RNA (tRNA)/ml, 1 mM DTT, 60 mCi of "C-
phenylalanine/ml (specific activity, 33 mCi/mmol),
300 ug of poly U/ml, 16 A2*,0 units of ribosomes/ml,
and 2 mg of supernatant enzymes/ml. After 45 min of
incubation at 30 C, reactions were stopped by the
addition of 1 ml of 10% trichloroacetic acid. The
precipitates were heated for 20 min at 90 C, cooled,
collected on glass-fiber papers, and counted.
For endogenous messenger RNA (mRNA)-directed
polypeptide synthesis, 400 ml of an active spheroplast
culture was poured over frozen 1 M sorbitol and the
thawed mixture was centrifuged for 15 min at 9,000 x
g. The pellets were resuspended in cold lysis buffer (3
ml), and DOC (0.15%) and Brij (0.2%) were added.
Lysis was assisted by three strokes in a Potter-Elvej-
hem homogenizer, and the lysate was centrifuged at
10,000 x g for 10 min to give an S-10 fraction. The
S-10 fraction was purified by passage through a
Sephadex G-50 column (previously equilibrated with
elution buffer, 10 mM Tris-hydrochloride, pH 7.4, 10
mM MgCl2, 40 mM KCI, and 5 mM DTT). The
RNA-rich fraction (monitored at OD2,,0) was eluted
with this buffer and stored in small portions in liquid
nitrogen. Incubation mixtures (0.1 ml) contained 50
mM Tris-hydrochloride, pH 7.4, 10 mM MgCl2, 80
mM KCl, 4 mM creatine phosphate, 40 Mg of creatine
phosphokinase/ml, 250 Mg of yeast tRNA/ml, 1 mM
DTT, 400 MM of the 20 amino acids, 5% (vol/vol) of
"4C-reconstituted algal hydrolysate (neutralized with
KOH), and 30 Mliters of purified S-10 fraction. Incu-
bation was for 45 min at 25 C, and radioactivity
incorporated into trichloroacetic acid precipitates was
determined out as described above.
Preparation ofRNA polymerases. RNA polymer-
ases were prepared from S. cerevisiae A364A cells
grown in YEPD medium as described in the accom-
panying paper. After breakage in a Buhler mill with
glass beads and sonic treatment, the 180,000 x g
supernatant fluid was fractionated on a column of
diethylaminoethyl (DEAE)-cellulose with a gradient
of increasing ammonium sulfate concentration (17).
The assay consisted of incorporation of (4-14C)-uri-
dine triphosphate (UTP) into a polymer retained by
DEAE paper during washing with 5% Na2HPO4 (2).
Precipitation with 5% trichloroacetic acid at 0 C and
filtration gave similar data. Unless otherwise stated,
all assays were performed at 30 C and contained 0.2
mg of alkali-denatured salmon sperm deoxyribonu-
cleic acid (DNA)/ml, 0.01 mM UTP, 0.2 mM adeno-
sin, guanosine, and cytidine triphosphate (ATP,
GTP, and CTP), 1.6 mM Mn2+, and 0.05 MCi of
"4C-UTP in a final volume of 100 Mliters. Counting
efficiency was 45%, so that the incorporation of 50
counts/min was equivalent to incorporation of 1 pmol
of UTP. Two peaks of activity, called I and II in order
of their elution from DEAE-cellulose, were consist-
ently recovered. Peak specific activities were usually
about 5 and 50 nmol of UTP incorporated per mg of
protein per h, respectively, and total enzyme II
activity was three to eight times total enzyme I
activity. Native salmon sperm DNA was about 80% as
effective as denatured DNA for enzyme I, but only 10
to 15% as effective for enzyme II. Both enzymes had
optimal activity in 1.5 to 2.5 mM Mn2+, and were
totally dependent on added template. "4C-UTP incor-
poration required the presence of all four nucleotide
triphosphates.
ANTIMICROB. AG. CHEMOTHER.
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MODE OF ACTION OF THIOLUTIN 731
Chemicals. Thiolutin was generously provided by
Nathan Belcher, Pfizer Inc., Groton, Conn. The drug
was made up freshly in dimethyl sulfoxide (DMSO)
before use. This solvent has been shown to have no
effect on growth, viability, or macromolecular proc-
esses in cells or spheroplasts at concentrations up to
1% (vol/vol). Cycloheximide was the gift of G. B.
Whitfield, Jr., The Upjohn Co., and cryptopleurine
was provided by S. F6ldeak. Yeast tRNA was pur-
chased from General Biochemicals Corp.; 3H-uridine
(26 Ci/mmol), 3H-adenine (36 Ci-mmol), and (4-14C)-
UTP, from Amersham Searle; and "4C-L-amino acid
mixture, from New England Nuclear Corp.
RESULTS
Effect of thiolutin on cell growth and via-
bility. Concentrations of antibiotic as low as 2
,ug/ml inhibited the growth of S. cerevisiae in
both rich and minimal media (Fig. 1). The drug
appears to have a static effect, since incubation
for 5 h with 100 ug of thiolutin/ml had no effect
on cell viability; cell growth resumed promptly
on removal of the drug.
Inhibition of macromolecular synthesis in
1.0
.5
E
0 /
w 2 4 6 8
HOURS
FIG. 1. Effect of thiolutin on growth of S. cerevi-
siae. Cell growth in 5-mi incubations was monitored
at OD550. The arrow indicates the time of addition of
the drug. Additions were as follows: 1% DMSO (0)
and thiolutin at 2 pg/mI (A), 5 mg/ml (V), 10 pg/mI
(0), and 25 ug/ml (A).
whole cells. Thiolutin caused rapid inhibition
of both protein and RNA synthesis in cells. A
typical incorporation experiment is shown in
Fig. 2; addition of thiolutin (4 ug/ml) immedi-
ately blocked the incorporation of 3H-uridine
into nucleic acids, and the incorporation of
"4C-amino acids into protein decayed to a mini-
mum over a period of about 20 min. This can
also be seen at lower concentrations of thiolutin,
where the differential effect of the drug on
protein and RNA syntheses is somewhat more
apparent. Figure 3 shows that 45 min after the
addition of thiolutin (1.5 ug/ml) uridine incor-
poration was reduced by 77% and protein syn-
thesis by 55%. Similar results were found when
incorporation into active yeast spheroplasts was
studied. Inhibition of DNA synthesis was also
observed, but this was not further analyzed.
The effect of thiolutin on the stability of RNA
was determined by adding the drug after a short
ANUTES
FIG. 2. Effect of thiolutin on the incorporation of
radioactively labeled uridine and amino acids into
cells of S. cerevisiae. Exponentially growing cultures
were divided into two parts, and 3H-uridine (6.6
ACi/ml) and "4C-amino acid mixture (0.66 ACi/mI)
were added to each. Thiolutin orDMSO was added at
20 min, and samples (I ml) were removed at the
indicated times and precipitated with trichloroacetic
acid (see Materials and Methods). Incorporation of
8H-uridine in the absence of drug (0) and in the
presence of thiolutin, 4 ;tg/ml (A). Amino acid incor-
poration in the absence (0) and in the presence (0) of
drug.
VOL. 3, 1973
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732 JIMENEZ, TIPPER, AND DAVIES
4 -4 Inhibition of polyribosome activity (freezing)
could result from inhibition of peptide bond
formation, translocation, or a variety of other
effects, such as starvation for an amino acid or a
/ / block in ATP production. The half-life of polyri-
o / bosomes after inhibition of mRNA production
3 33 has been used to determine mRNA stability,
/ / and studies with a yeast mutant have indicated
that the half-life of mRNA in S. cerevisiae is 23
/ ,' I min at 36 C (13). When thiolutin (4 ,ug/ml) was
v /,' w added to an active culture of spheroplasts and
x O ,' 2 the culture was examined periodically for poly-
C ribosome content, it was found that degradation
of polyribosomes occurred, and after 60 min less
than 20% of the ribosomes were present in
0/, ,/ ~~~~polyribosomes (Fig. 4). The polyribosome "run-
/offs occuring after the addition of thiolutin is
presumed due to the normal movement of1
,/^/ s o- ribosomes in protein synthesis, since it is com-
pletely blocked by the addition of inhibitors of
g/,8,° ______. protein synthesis in yeast, e.g., cycloheximide,
o f anisomycin or cryptopleurine.
At low thiolutin concentrations (2 to 4 Ag/ml),
the half-life of polyribosome run-off in sphero-
10 20 30 40 50 60
FIG. 3. Effect of low concentrations of thiolutin on A7
the incorporation of precursors of RNA and protein .2 - X
synthesis. Exponential cultures of S. cerevisiae in
YM-5 received 3H-uridine (10 jiCi/mI) and "4C-amino
acids mixture (1 gCi/ml). After 2 min of incubation,
additions were made as indicated, and samples were
taken as described in Materials and Methods. 3H-uri- Iidine control (0), 3H-uridine in the presence of 1.5 Mg
of thiolutin/mI (0), 3H-uridine in the presence of 2.5
,ug of thiolutin/ml ($). "4C-amino acid control (0), E
"4C-amino acids in the presence of 1.5 Mg of thi- M o - - - -, V
olutin/mI (A&), "C-amino acids in the presence of 2.5 cl 1.3
jig of thiolutin/mI (V). _ D E F
.2-
(1 to 2 min) pulse of3 H-uridine. Over a range of
4 to 100 Mg of thiolutin/ml for periods of up to 1 |,h, labeled RNA was stable and did not break .1 -
down into trichloroacetic acid-soluble material.
This is in marked contrast to the situation in
bacteria, where inhibition of RNA synthesis
results in a rapid decay of unstable RNA oU
labeled by the short pulse (14). In HeLa cells, FIG. 4. Effect of thiolutin on the stability ofpolyri-
inhibition of RNA synthesis by actinomycin bosomes. Spheroplasts from S. cerevisiae in YM-5
does not presage decay of synthesized RNA medium containing 0.4 M MgSO4 were treated with
(19). thiolutin (4 Mg/ml) and incubated at 30 C. Samples (5
Effect of thiolutin on polyribosome metabo- ml) were removed at various times, lysed, and
lism in spheroplasts. The presence or absence analyzed on 10 to 30% sucrose density gradients as
of polyribosomes in spheroplasts can provide a described in Materials and Methods. Panel A is zero
useful indicator of the mode of action of a drug time, no drug, and panel D is 60-mn incubation, nouseful indicator ofthe of actlon of a drug drug. Panels B, C, E, and F indicate polyribosome
(5). Decay ("run-off') of polyribosomes can profiles after incubation with drug for respectively 5,
result from inhibition ofRNA synthesis or from 15, 30, and 60 min. The arrows indicate the position of
interference with initiation of protein synthesis. 80s monomers on the gradients.
ANTIMICROB. AG. CHEMOTHER.
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MODE OF ACTION OF THIOLUTIN 733
plasts of S. cerevisiae is 15 to 20 minutes at 24
C. This value is of the same order of magnitude
as that found by Hutchison et al. (13) in a
different yeast strain. The run-off of polyribo-
somes after addition of thiolutin is never com-
plete, and the decay curves are biphasic (Fig.
5A). The half-life of polyribosome decay during
the first 15 min is shorter than that at later
times, which might indicate the existence of
more than one population of polyribosomes or
differential effects of the drug on RNA and
protein synthesis. At concentrations of 10 ug/ml
and higher, thiolutin partially inhibited the
rapid phase of polyribosome run-off (Fig. 5B),
and we assume that the drug begins to have
secondary, nonspecific effects at these concen-
trations. Partial inhibition of polyribosome me-
tabolism cannot be due to an effect on translo-
cation since the drug has little or no effect on
polypeptide synthesis in vitro.
Thiolutin has no effect on in vitro polypep-
tide synthesis. The effect of thiolutin on cell-
free protein synthesis has been tested in two
different systems. In one, amino acid incorpora-
tion was directed by endogenous mRNA in an
S-10 extract prepared by lysis of active sphero-
plasts. As shown in Table 1, thiolutin at 100
,gg/ml was only slightly inhibitory. In a more
purified system, with the use of poly U-directed
phenylalanine incorporation, the drug was
equally ineffective. Since these two amino acid
incorporation systems do not assay for all of the
steps in protein synthesis (it is unlikely that
normal initiation or termination occur), we can
conclude only that thiolutin does not inhibit
translocation or peptide bond formation, which
is consistent with the inability of the drug to
inhibit polyribosome run-off in sphereoplasts.
Effect of thiolutin on the synthesis and
processing of stable RNA. In whole cells and
spheroplasts, the addition of low concentrations
of thiolutin leads to the rapid inhibition of
uridine incorporation. This implies that the
synthesis of all species of RNA is inhibited.
Udem and Warner (20) have shown that, when
yeast is treated with protein synthesis inhibi-
tors, some RNA synthesis continues but the
cells are blocked in the processing of the 37s
ribosomal RNA (rRNA) precursor. The follow-
ing experiment was carried out to determine
MINUTES MNUTES
FIG. 5. Effect of different thiolutin concentrations on polyribosome "run-off" in S. cerevisiae spheroplasts.
Experimental details are as described in Fig. 4 and in Materials and Methods. Polyribosome patterns were de-
termined at the indicated times after treatment with various concentrations of thiolutin. (A) Low concentra-
tions of thiolutin: no drug (V), 0.5 gg/ml (0), 1 ;ig/ml (0), 2 gg/ml (0), and 3 Mg/ml (A). (B) High concentra-
tions of thiolutin. No. drug (V), 4 ig/ml (0), 10 ,g/ml (0), 20 ug/ml (0), and 50 ug/ml (A).
VOL. 3, 1973
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734 JIMENEZ, TIPPER, AND DAVIES
TABLE 1. Effect of thiolutin on polypeptide synthesis
in vitro
System Additions Counts Percentmin inhibition
Endogenous None 1,420
incorporation DMSO, 2% 1,480
Thiolutin,
10 jg/mi 1,480
50 Ag/ml 1,320 11
100 jg/ml 1,170 21
Anisomycin,
5 jg/ml 460 68
Cycloheximide,
10 jig/ml 575 60
Poly U-di- None 28,660 -
rected DMSO, 2% 28,900 0
Thiolutin,
10 jig/ml 28,120 0
100 ug/ml 29,690 0
Cycloheximide,
5 jig/ml 7,145 75
whether thiolutin also inhibits the processing of
rRNA species in yeast. The stable RNA species
(15s and 27s) were labeled by growing S.
cerevisiae cells in the presence of "4C-adenine,
and the cells were converted to spheroplasts.
The spheroplasts were incubated in YM-5 to
restore metabolic activity and then were pulse-
labeled for 2 min with3H-uridine; in this short
period, the label would enter mRNA and the
large-molecular-weight rRNA precursor. Por-
tions of the pulse-labeled culture were treated
in various ways (see Fig. 6), lysed, and analyzed
to 5 to 20% sucrose gradients containing SDS.
In this experiment, we have used cryptople-
urine as the protein synthesis inhibitor; in the
presence of this drug, further processing of the
large precursor RNA is blocked. Identical re-
sults were obtained with cyclohexamide and
anisomycin, and with thiolutin. Thiolutin in-
hibits the synthesis of all species of RNA and
blocks the processing of precursor RNA.
Inhibition of yeast RNA polymerases by
thiolutin in vitro. Since thiolutin was found to
inhibit RNA synthesis in whole cells and sphe-
roplasts of S. cerevisiae, we examined the sensi-
tivity of an in vitro transcription system to this
antibiotic, with the notion that this might
represent the primary mode of action of the
drug. The synthetic activity of RNA polym-
erases I and II from S. cerevisiae was found to be
sensitive to low levels of the drug (Fig. 7). The
degree of inhibition of the RNA polymerases
depended on the assay procedure. Sensitivity
was greatest if the enzyme was preincubated
with thiolutin; enzymes I and II were 50%
ANTIMICROB. AG. CHEMOTHER.
inhibited by 3 and 6 Ag of thiolutin/ml, respec-
tively (Fig. 7). In a number of experiments, it
was found that preincubation of the drug with
enzymes but not preincubation of drug and
template enhances the inhibitory action of thi-
olutin on RNA synthesis; this would suggest
that the site of action of thiolutin in inhibiting
RNA synthesis is the enzyme and not the
template. In all in vitro experiments, the pres-
ence or absence of a sulfhydryl reagent did not
affect the inhibitory action of the drug.
Reversibility of thiolutin inhibiton. Since
incubation with thiolutin does not affect yeast
cell viability, it was of interest to examine the
timing of recovery of macromolecular synthesis
after removal of the drug. Cultures of cells and
spheroplasts were exposed to thiolutin (8,ug/ml)
for 90 min, washed, and resuspended in medium
containing radioactive precursors for RNA and
protein synthesis, but lacking the drug. The
cultures were then incubated and samples were
taken at intervals to determine when RNA and
protein synthesis were restored to normal. In
Fig. 8 it can be seen that macromolecular
synthesis was restored on removal of the drug
and the rate of synthesis rapidly attained that
of the uninhibited controls. Whole cells and
spheroplasts behave differently in their recovery
from thiolutin inhibition. In cells, protein syn-
thesis recovers more rapidly than RNA synthe-
sis, whereas in spheroplasts protein and RNA
synthesis recover at approximately the same
time. This difference may be only trivial, but it
is known that spheroplasts tend to leak RNA
(12), and it is possible that protein synthesis in
spheroplasts is delayed as a consequence of
leakage during thiolutin treatment. Not surpris-
ingly, removal of thiolutin and restoration of
macromolecular synthesis are accompanied by
re-formation of polyribosomes (Fig. 9).
DISCUSSION
S. cerevisiae is a eukaryotic organism which is
susceptible to facile genetic manipulation and
biochemical study; it thus provides a good
model system for studies of the synthesis and
regulation of macromolecular synthesis in euka-
ryotes. The studies of Hartwell, McLaughlin,
and Warner have provided much basic informa-
tion on macromolecular synthesis in S. cerevi-
siae; a large number of temperature-sensitive
mutants have been isolated (9), and various
mutants have been characterized with blocks in
cell division, protein, and RNA synthesis. The
use of antibiotic inhibitors of protein synthesis,
such as cycloheximide, has also been helpful in
determining relationships between the synthe-
sis of various macromolecules in yeast.
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FIG. 6. Effect of thiolutin on the synthesis and processing of stable RNA species. Spheroplasts were pre-
pared from S. cerevisiae cells which had been grown overnight in the presence of "C-adenine (0.125 uCi/ml)
to indicate steady-state labeling. 3H-uridine (30 uCi/ml) was added to various 5-ml spheroplast cultures, which
were incubated at 27 C. One culture (control) was poured over frozen 1.0 M sorbitol after 2 min of incubation. To
the remaining cultures, unlabeled uridine (final concentration, 0.5 mg/ml) was added, and incubation was con-
tinued for 20 min, with additions as indicated. Spheroplasts were lysed, and gradients were collected and ana-
lyzed as described in Materials and Methods. (A) Control, 3H-uridine for 2 min. (B) 3H-uridine for 20 min. (C)
3H-uridine for 2 min, thiolutin (10 pg/ml) and unlabeled uridine for 20 min. (D) 3H-uridine for 2 min, crypto-
pleurine (60 pig/mI) and unlabeled uridine for 20 min.
Yeast RNA polymerase was first fractionated
by Frederick et al., who probably isolated only
the relatively stable enzyme II activity (8).
More recently, by use of the procedure of Roeder
and Rutter (17), multiple peaks of activity have
been obtained, as first demonstrated by Roeder
(2). Fractionation on DEAE-cellulose usually
given only two peaks of activity, I and II, in that
order. Only peak II is sensitive to a-amanitin (6,
16; D. J. Tipper, J. Bacteriol., in press; Sebas-
tian, Bhargava, and Halvorson, Abstr. Annu.
Meet. Amer. Soc. Microbiol., p. 162, 1972)
FRACTION NUMBER
VOL. 3, 1973 735
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736 JIMENEZ, TIPPER, AND DAVIES
juJc/ml ANTIBIOTIC
FIG. 7. Inhibition ofyeast RNA polymerases ( and
II) by thiolutin. Enzyme (20 tliters ofDEAE-cellulose
column fraction) was incubated at 22 C in 50 mM
Tris-hydrochloride buffer (pH 7.9 at 22 C), 1.6 mM
MnCl2, 0.4 mMDTT, 0.8 mM KPO4, 0.2 mMEDTA,
and dimethyl sulfoxide (2%) containing the indicated
concentrations of thiolutin or a-amanitin. After 5
min, DNA template and nucleotide triphosphates
(including 0.05 uCi of "C-UTP) were added (final
volume of incubation, 100 jliters), and incubation
was continued for 20 min at 30 C before assaying for
amqunt of RNA synthesized. Thiolutin (U), a-
amanitin (0). If thiolutin, DNA template, the other
assay components, and enzyme were rapidly mixed in
that order at 0 C and subsequently incubated for 20
min at 30 C, the inhibition of RNA synthesis by
thiolutin was reduced (A).
though three peaks have been reported (3). On
the other hand, fractionation on DEAE-
Sephadex usually gives a third peak of activity
(III) eluting after II. III, like I, is resistant to
a-amanitin (1, 2, 15; Tipper, in press). Hall et
al. (1) also found a fourth peak of activity
eluting before I. The pattern of three RNA
polymerase fractions, I, II, and Ill, with II being
sensitive to a-amanitin, is common to most
eukaryotic organisms investigated. In meta-
zoans, only I is found in isolated nucleoli, and it
is believed to be responsible for rRNA synthesis
(2). It would be convenient if a good inhibitor of
RNA synthesis were known for S. cerevisiae;
actinomycin and rifamycin have been used
extensively in studies of eukaryotes and proka-
ryotes, but neither of these inhibitors is effective
against yeast. We therefore sought an inhibitor
of RNA synthesis that would be effective in this
organism, and this communication summarizes
our studies on thiolutin, a sulfur-containing
antibiotic, which is a potent antifungal agent
(9). We have shown that the drug is effective
against S. cerevisiae; it is static in its action and
the inhibitory effect of the drug is easily reversi-
ble. The inhibitory effect of the drug on yeast
RNA polymerases in vitro at relatively low
concentrations would suggest that the primary
site of action of thiolutin is at the level of
transcription. However, this conclusion is not
entirely in agreement with the results of experi-
ments on inhibition ofRNA and protein synthe-
sis in cells and spheroplasts, since inhibition of
protein synthesis occurs shortly after the cessa-
tion of RNA synthesis. These inconsistencies
could be explained by any of the following
possibilities.
(i) Thiolutin is primarily an inhibitor of en-
ergy metabolism in cells, which also binds to
yeast RNA polymerases and inhibits their ac-
tion in vitro. This possibility is difficult to prove
or disprove. Thiolutin does not inhibit the
incorporation of "4C-labeled glucose into tri-
chloroacetic acid-insoluble material in whole
cells at concentrations when RNA synthesis is
shut off (unpublished data), which may imply
no effect of the drug on ATP production (10). In
thiolutin-inhibited spheroplasts, polyribosomes
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FIG. 8. Recovery of macromolecular synthesis after
removal of thiolutin. An exponential culture of S.
cerevisiae was divided, and one half was treated with
thiolutin (8 gg/ml) for 2 h at 27 C. Both batches of
cells were washed three times with water; the pellets
were resuspended in fresh YM-5 medium containing
3H-uridine (6.6 MCi/ml) and "4C-amino acid mix (0.66
/uCi/ml) and were incubated at 27 C. Samples were
taken for trichloroacetic acid-precipitable radioactiv-
ity (at the times indicated). (A) Incorporation of
'H-uridine: control (0); thiolutin-treated (0). (B)
Incorporation of "4C-amino acids; control (0); thi-
olutin-treated (0).
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MODE OF ACTION OF THIOLUTIN 737
are active, and this activity is blocked by
inhibitors of protein synthesis. Since protein
synthesis cannot take place without a continued
source of ATP, it is unlikely that thiolutin
affects energy generation.
(ii) Thiolutin inhibits RNA synthesis and
protein synthesis by a primary effect on protein
synthesis (initiation or termination). It is
known that RNA and protein syntheses in yeast
are coupled in some way (18), and inhibition of
protein synthesis causes a cessation of RNA
synthesis. If initiation of protein synthesis was
inhibited by thiolutin, it would be expected that
polyribosomes would be unstable and would no
longer be seen after incubation of spheroplasts
for about 5 min. It is believed that the average
time for the completion of polypeptide chains is
1 minute in yeast spheroplasts (11). In fact, 15
to 20 min after the addition of thiolutin, 50% of
the ribosomes are still present in polyribosomes.
This result is also not consistent with inhibition
of the elongation or completion (termination) of
polypeptide chains, since this would lead to
"freezing" of the polyribosomes. However, thi-
olutin blocks the processing of the 37s rRNA
precursor, which is typical of the mode of action
of inhibitors of protein synthesis such as cy-
cloheximide, anisomycin, or cryptopleurine.
(iii) Thiolutin inhibits RNA synthesis as its
primary mode of action, but also has secondary
effects on protein synthesis and other metabolic
processes. Many antibiotics with a single mode
of action at one concentration have multiple,
secondary effects at higher concentrations. In
vitro polypeptide synthesis experiments show
that thiolutin does not inhibit translocation or
peptide bond formation, even at high concen-
tration (100 ug/ml). However, it is possible that
some steps taking place in polypeptide synthe-
sis in whole cells may not be assayed in these
systems.
(iv) Thiolutin inhibits RNA synthesis as pri-
mary mode of action and, because of coupling
between the two macromolecular processes,
concomitantly causes inhibition of protein syn-
thesis. This would imply that the control of
RNA and protein synthesis in S. cerevisiae is
coupled and stringent in both directions.
It has been established that RNA and protein
synthesis in S. cerevisiae are coupled and that
inhibition of protein synthesis by amino acid
starvation, or with any one of several antibiotics
(cycloheximide, anisomycin, or cryptoplurine),
results in rapid cessation of RNA synthesis (8,
18). This may parallel the coupling between
RNA and protein synthesis found in stringently
controlled bacterial cells (7), but it is also
possible that, in yeast, this inhibition is the
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FIG. 9. Re-formation of polyribosomes after re-
moval of thiolutin inhibition. A spheroplast culture in
YM-5 containing 0.4 M MgSO4 was divided into two
parts, and one half was treated with thiolutin (8
tg/ml); the two cultures were incubated at 27 C for 90
min. Samples (5 ml) were taken from each culture
and chilled in ice in the presence of 200 gg/ml of
cycloheximide. The remainders of the two cultures
were centrifuged; the spheroplasts were washed by
centrifugation and resuspended in fresh YM-5 me-
dium containing 0.4 M MgSO4. The two cultures
were incubated at 27 C and, periodically, 5-mi sam-
ples were removed, lysed, and analyzed for polyribo-
some content as described in Materials and Methods.
(0) Control, spheroplast culture not treated with thi-
olutin; (0) culture after removal of thiolutin.
result of failure to process the large rRNA
precursor (20), an accumulation of which might
lead to feedback inhibition ofRNA synthesis. It
is not inconceivable that RNA synthesis and
protein synthesis in yeast are interdependent,
and inhibition of RNA synthesis would lead to a
rapid cessation of protein synthesis. At present,
there is no evidence and no precedent for such a
mechanism, and it is difficult to think of a
resonable mechanism. We favor the notion that
the primary effect of thiolutin may be on the
transcription system, but secondary effects of
the drug lead to inhibition of other processes
(model iii). Thiolutin also inhibits DNA synthe-
VOL. 3, 1973
 o
n
 July 9, 2019 by guest
http://aac.asm
.org/
D
ow
nloaded from
 
738 JIMENEZ, TIPPER, AND DAVIES
sis in S. cerevisiae (unpublished data); how-
ever, because of difficulties in monitoring DNA
synthesis in yeast, these experiments are not
conclusive. A direct demonstration of the site of
action of thiolutin might come from studies of
thiolutin-resistant mutants of S. cerevisiae.
Unfortunately, to date, no stable thiolutin-
resistant mutants have been obtained.
It is of interest that low concentrations (< 10
,gg/ml) of thiolutin are required to inhibit me-
tabolism of whole cells or spheroplasts of S.
cerevisiae, and similar low concentrations are
sufficient to produce marked inhibition of the
function of yeast RNA polymerases in vitro.
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